Dumont-UCLA Transplant Center, Dumont-UCLA Liver Cancer Center, and Pfleger Liver Institute
Earn 6.0 AMA PRA Category 1 Credits™ and CEPTCs
Saturday, October 17, 2026
Hyatt Regency Westlake Westlake Village, CA
A one-day CME program delivering the latest clinical insights in liver disease diagnosis, management, and multidisciplinary care.
COURSE DIRECTORS
Sammy Saab, MD, MPH
Professor of Medicine and Surgery
David Geffen School of Medicine at UCLA
Medical Director, Pfleger Liver Institute
Medical Director, Adult Liver Transplant Program
Chief, Transplant Hepatology
Head, Outcomes Research in Hepatology
Adjunct Professor of Nursing
Fady M. Kaldas, MD, FACS
Professor of Surgery
David Geffen School of Medicine at UCLA
Kelly Lee Tarantello Chair in Liver Transplantation
Surgical Director, Adult Liver Transplant Program
Director, Multi-Organ Transplantation Fellowship Program
Director, Liver Transplant Service
Co-Director, Heart-Liver Disease Program
AGENDA
7:00–7:15 AM
Registration, Breakfast, and Exhibits* (Plaza de Barcelona)
7:15–8:00 AM
Rezdiffra: Unlocking The Potential of Liver-Directed Treatment
Julio Gutierrez, MD
Industry-Sponsored Event* (Plaza de Barcelona)
Sponsored by Madrigal Pharmaceuticals
8:00–8:15 AM
Break and Visit Exhibits* (Plaza de Barcelona)
8:15–8:20 AM
Conference Overview (Plaza de Barcelona)
Sammy Saab, MD, MPH
Session 1: Steatotic Liver Disease Spectrum: ALD and MASLD (Plaza de Cataluna)
8:20–8:40 AM
Risk Assessment and Pharmacologic Treatment of MASLD
Carrie Wong, MD, PhD
8:40–9:00 AM
Drugs and Lifestyle for Weight Loss
Mike Garcia, MD
9:00–9:20 AM
Assessment and Treatment of Alcoholism
Julio Meza, MD
9:20–9:40 AM
MetALD Implications
Jason Pan, MD
9:40–9:55 AM
Q&A / Panel Discussion
9:55–10:10 AM
Break and Visit Exhibits* (Plaza de Barcelona)
Session 2: Cirrhosis and Portal Hypertension
(Plaza de Barcelona)
10:10–10:30 AM
Screening of Hepatocellular Carcinoma: Update on Candidates and Tools
Jihane Benhammou, MD, PhD
10:30–10:50 AM
The Modernization of Machine Perfusion: A Surgical Perspective
Samer Ebaid, MD, PhD, MS
10:50–11:10 AM
New Concepts in Cirrhosis (cACLD)
Akshay Shetty, MD
11:10–11:30 AM
BRTO/CRTO in Patients with Advanced Liver Disease
Edward W. Lee, MD, PhD
11:30–11:45 AM
Q&A / Panel Discussion
11:45 AM–12:00 PM
Lunch and Visit Exhibits* (Plaza de Barcelona)
12:00–12:45 PM
Industry-Sponsored Event* (Plaza de Barcelona)
Sponsored by Ipsen Biopharmaceuticals
12:45–12:55 PM
Break and Visit Exhibits* (Plaza de Barcelona)
Session 3: Hepatitis and Cholestatic Liver Disease (Plaza de Cataluna)
12:55–1:15 PM
Immune-Mediated Hepatitis: Diagnosis and Management
Brian Horwich, MD, MS
1:15–1:35 PM
Primary Biliary Cholangitis: Improving Patient Care
Sentia Iriana, MD, MS
1:35–1:55 PM
Drug Induced Liver Injury: Evaluation and Management
Gina Choi, MD
1:55–2:15 PM
What is New in Viral Hepatitis B and D
Sammy Saab, MD, MPH
2:15–2:30 PM
Q&A / Panel Discussion
2:30–2:45 PM
Break and Visit Exhibits* (Plaza de Barcelona)
Session 4: Advanced Topic and Advanced Treatments (Plaza de Cataluna)
2:45–3:45 PM
Navigating the Cascade of Care in Hepatic Encephalopathy Accredited Symposium
Sammy Saab, MD, MPH
3:45–4:05 PM
New Indications For Liver Transplant: Colorectal Cancer and Cholangiocarcinoma
Vatche Agopian, MD
4:05–4:25 PM
Increasing Liver Transplant Donor Pool Through Pump and Living Related Donation
Fady Kaldas, MD, FACS
4:25–4:45 PM
Current Treatments of Hepatocellular Carcinoma
Richard Finn, MD
4:45–5:00 PM
Q&A / Panel Discussion
5:00–5:05 PM
Conference Summary & Closing Remarks
Douglas Farmer, MD
5:05 PM
Adjourn
Hyatt Regency
Westlake
880 S Westlake Blvd
Westlake Village, CA 91361